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ABSTRACT 
Introduction: The biological mechanisms through which increased physical activity or 
structured exercise training lowers the risk of recurrent cardiac events are incompletely 
understood. We examined the extent to which modification of primary risk markers explains 
the association between physical activity and cardiovascular death in participants with 
diagnosed cardiovascular disease (CVD). 
Methods and Results: In a prospective study of 1429 participants with physician-diagnosed 
CVD living in England and Scotland (age = 66.5 ± 11.1 yr (mean ± SD), 54.2% men), we 
measured physical activity and several risk markers (body mass index, total-to-HDL 
cholesterol ratio, diagnosed diabetes, systolic blood pressure, resting heart rate, C-reactive 
protein) at baseline. The main outcome was CVD death. There were a total of 446 all-cause 
deaths during an average of 7.0 ± 3.1 yr of follow-up, of which 213 were attributed to 
cardiovascular causes. Participation in moderate to vigorous physical activity at least three 
sessions per week was associated with lower risk of CVD death (hazard ratio = 0.61, 95% 
confidence interval = 0.38–0.98). Physically active participants demonstrated significantly 
lower levels of body mass index, diabetes, and inflammatory risk (C-reactive protein). 
Metabolic (body mass index, total-to-HDL cholesterol ratio, and physician-diagnosed 
diabetes) and inflammatory risk factors explained an estimated 12.8% and 15.4%, 
respectively, of the association between physical activity and CVD death. 
Conclusions: Physical activity may reduce the risk of secondary CVD events, in part, by 
improving metabolic and inflammatory risk markers. 
 
  
The most recent and comprehensive meta-analysis concluded that structured exercise 
training improves survival and reduces recurrent events in coronary heart disease (CHD) 
patients (3). However, all randomized controlled trials considered were published before 
2000, and participants were primarily middle-age, low-risk males with CHD. Supervised 
exercise training trials are considered the gold-standard experimental design to assess the 
efficacy of exercise in treating CHD. However, most programs are generally limited to 6 
months followed by unsupervised physical activity with a mean follow-up of approximately 
2.5 yr. Although susceptible to biases such as residual confounding, epidemiological cohort 
studies have the added advantage of following participants for longer periods of time to 
assess hard clinical end points. Few studies have prospectively examined the association of 
leisure time physical activity on mortality among participants with established CVD in a 
general population (2,5,8,9,12,22,25). 
The British Regional Heart Study previously reported that the beneficial effects of physical 
activity and changes therein on 4-yr mortality rates were limited to light and moderate levels 
in males with a wide range of preexisting cardiovascular disease (CVD) (22). Data from the 
original Framingham Heart Study showed that moderate and high physical activity levels 
resulted in improved life expectancy of 1.3 and 3.7 yr, respectively, among participants with 
a history of CVD (5). Moreover, the biological mechanisms through which physical activity 
lowers the risk of recurrent events remain incompletely understood. Exercise training studies 
in cardiac patients demonstrate modest but consistent improvements in various risk factors, 
such as cardiac performance, aerobic capacity, endothelial function, and inflammatory 
markers (4,6,11,24). We recently demonstrated that inflammatory risk factors and blood 
pressure made the largest contribution to the inverse association between physical activity 
and CVD events in a healthy sample (7). However, limited prospective epidemiological data 
that have evaluated the influence of protective mechanisms underlying the relationship 
between physical activity and reduced CVD deaths exist in participants with preexisting 
CVD. Thus, the aim of this study was to further examine the association between moderate 
to vigorous leisure time physical activity and risk of CVD death in patients with diagnosed 
CVD. Second, we examined the extent to which cardiometabolic risk factors explain the 
association between physical activity and cardiovascular death in these participants. 
  
METHODS 
  
Study design and participants 
Participants were recruited into the Health Survey for England and Scottish Health Survey, 
both representative, general population-based studies sampling individuals living in 
households in each country (18). Consenting study members (90% in Health Surveys for 
England, 82.5% in Scottish Health Surveys) were linked to National Health Service 
mortality data. Study participants gave full informed consent, and ethical approval was 
obtained from the London Research Ethics Council. At baseline, a total of 6271 participants 
reported physician-diagnosed ischemic heart disease or stroke (5.7% of the overall sample), 
although only 46.3% (n = 2903) consented to a nurse visit. A further 1474 participants had 
missing demographic data; thus, the present analyses contained 1429 participants (age = 
66.5 ± 11.1 yr, 54.2% male). Excluded participants (n = 4842) were older (68.0 vs 66.4 yr, P 
< 0.001) than those included, although there were no differences in sex distribution (47.4% 
vs 45.3% female, P = 0.15), and the cardiovascular death rate was also similar (16.1% vs 
14.6%, P = 0.16). 
  
Demographic and clinical variables 
Computer-assisted personal interviewing modules assessed respondents’ demographics, 
health status and history of disease, and health behaviors (smoking and physical activity 
habits). Frequency of moderate to moderate-vigorous physical activities (MVPA) in the 4 
wk before the interview, including sessions lasting for at least 30 min (walking and heavy 
domestic) or 15 min (recreational sports and structured exercise), was assessed. The 
definition of MVPA was based on activities greater than 3 METs (1). The validity of the 
physical activity questionnaire is supported by objective measures of activity using 
accelerometry devices in 106 British adults from the general population (10). 
In a separate visit within a few days, qualified nurses recorded medication ([beta]-blockers, 
angiotensin-converting enzyme inhibitors, diuretics, calcium blockers, lipid-lowering 
medications), measured height and body mass, collected blood samples, and measured 
seated blood pressure and resting heart rate (using an Omron HEM-907 [Omron Europe, 
Hoofddorp, The Netherlands] blood pressure monitor) three times after 5 min of rest in 
between each reading. Blood samples were analyzed for C-reactive protein (CRP) and total 
and HDL cholesterol. The analysis of CRP levels from serum was performed using the N 
Latex High-Sensitivity CRP mono immunoassay on the Behring Nephelometer II analyzer 
(Dade Behring, Newark, Germany). The limit of detection was 0.17 mg·L-1, and the 
coefficient of variation was <6%. Total and HDL cholesterol was measured using 
cholesterol oxidase assays on an Olympus 640 analyzer (Olympus, Center Valley, PA). 
Diabetes was ascertained from a self-reported physician’s diagnosis. 
  
Mortality follow-up 
Classification of the underlying cause of death was based on information collected from the 
death certificate together with any additional information provided subsequently by the 
certifying doctor. Diagnoses for primary cause of death were recorded using the 
International Classification of Diseases, 9th and 10th revisions. We used codes 390-459 
(ICD-9) and I01-I99 (ICD-10) to identify cardiovascular death. 
  
Statistical analyses 
MVPA was categorized into three groups corresponding to none, less than three sessions per 
week, and three or more per week. We used an ANOVA with Scheffe post hoc tests to 
examine the association between MVPA categories and CVD risk factors. The CRP data 
were log transformed to normalize the distribution. We used Cox proportional hazards 
models to compute hazard ratios (HR) with accompanying 95% confidence intervals (CI) for 
the association between MVPA and cardiovascular/all-cause death. The proportional hazards 
assumption was examined by comparing the cumulative hazard plots grouped on exposure, 
although no appreciable violations were noted. In these analyses, calendar time (months) 
was the time scale. For participants who remained alive, the data were censored on February 
28, 2008, in the Health Survey for England and December 30, 2008, in the Scottish Health 
Survey. To test the extent to which CVD risk factors account for the association between 
MVPA and cardiovascular death, we a priori grouped together CVD risk factors considered 
to be potential mediators. This included metabolic (body mass index, total–HDL cholesterol 
ratio, diabetes), cardiovascular (systolic blood pressure, resting heart rate), and inflammatory 
(CRP) risk factors. Because these risk factors are known to be associated with one another, 
all models were mutually exclusive of one another and also adjusted for other potential 
confounders including age, sex, smoking, and use of cardioprotective medication (yes/no). 
The percentage change in HR after multiple adjustments in comparison with the basic (age, 
sex, smoking, and medication adjusted) model was quantified as follows: (HRbasic model - 
HRadjusted)/(HRbasic model -1) × 100 (7). Key to interpretation is the degree of attenuation in the 
MVPA–CVD relation after adjustment, not whether the association remains significant. A 
statistical significance of P < 0.05 was used throughout. All analyses were conducted using 
SPSS version 14 (IBM Corp., Armonk, NY). 
  
RESULTS 
  
Baseline characteristics 
Approximately 44.0% of the sample reported undertaking some weekly MVPA. Those 
participants (16%) undertaking at least three sessions per week of MVPA were younger, 
more likely to be men, nonsmokers, not taking medication, and had a more favorable 
physiological risk profile (including lower adiposity, CRP, and resting heart rate and less 
diabetes) (Table 1). 
 
  
Physical activity and risk of death 
There were a total of 446 all-cause deaths during an average of 7.0 ± 3.1 yr of follow-up, of 
which 213 were attributed to cardiovascular causes. Participation in three or more sessions a 
week of MVPA was associated with lower risk of all-cause (HR = 0.52, 95% CI = 0.37–
0.74) and cardiovascular death (HR = 0.61, 95% CI = 0.38–0.98), after adjustment for age, 
sex, smoking, and medication. To exclude the possibility of reverse causation, we removed 
all deaths occurring in the first 2 yr of follow-up (n = 99), although this did not affect the 
results (adjusted HR for all-cause death = 0.48, 95% CI = 0.32–0.73). In the original sample 
of participants with available data on physical activity and basic confounders (n = 5145), we 
observed similar associations of three or more sessions per week of MVPA with all-cause 
death (HR = 0.44, 95% CI = 0.37–0.53) and CVD death (HR = 0.43, 95% CI = 0.32–0.58) 
after adjustment for age, sex, smoking, and medication. Thus, these results confirm that the 
subsample used in the present analyses is largely representative of the overall cohort, 
although small differences exist in the magnitude of the effect estimates. 
  
Biological mediators 
In multivariate models, the risk factors independently associated with cardiovascular 
death included total–HDL cholesterol ratio (HR per unit = 1.07, 95% CI = 1.02–1.12), 
natural logarithmic transformation CRP (HR per unit = 1.29, 95% CI = 1.08–1.53), and 
diabetes (HR = 1.92, 95% CI = 1.34–2.74). Metabolic and inflammatory risk factors 
explained an estimated 12.8% and 15.4% of the association between MVPA and CVD 
death, respectively (Table 2). Cardiovascular factors, including blood pressure and resting 
heart rate, did not explain any amount of the association. When we repeated the analyses 
excluding 365 participants taking [beta]-blockers, this did not change the results. In total, 
all risk factors collectively explained an estimated 25.6% of the MVPA–CVD death 
association. 
   
 
  
Behavioral mediators 
To address the issue of behavioral mediators, we also conducted further analyses to examine 
the contribution of smoking and medication adherence. In models adjusted for only age and 
sex, participation in three or more sessions a week of MVPA was associated with even lower 
risk of cardiovascular death (HR = 0.53, 95% CI = 0.33–0.85). With the addition of smoking 
to the model, the effect estimate was attenuated (HR = 0.60, 95% CI = 0.37–0.96), 
suggesting that smoking explained an estimated 14.9% of the MVPA–CVD death 
association. 
  
DISCUSSION 
Previous evidence suggests that leisure time physical activity is important for secondary 
prevention in participants diagnosed with CVD, although the precise mechanisms remain 
incompletely understood. In the present sample of men and women with physician-
diagnosed CVD from two representative health surveys, leisure time physical activity was 
associated with lower risk of both all-cause and cardiovascular deaths that confirms previous 
prospective cohort studies (2,5,8,9,12,22,25). We previously reported an inverse association 
between physical activity and mortality in men and women with existing CVD followed up 
for a shorter period in the Scottish Health Survey (8). This association was largely explained 
by engaging in moderate-vigorous activities such as sports and walking but not by light 
activities that included domestic work. This is possibly due, in part, to the lack of precise 
reporting of light activities. 
The main finding from the present study was that, additional to the risk attributable to lower 
smoking prevalence, metabolic and inflammatory mechanisms explained a modest amount 
of the association between MVPA and CVD death. A previous work has examined the 
reduction in cardiac mortality attributable to changes in risk factors (total cholesterol, 
systolic blood pressure, and smoking) from randomized controlled trials of cardiac 
rehabilitation (21). Exercise-only training reduced pooled cardiac mortality by 28% (relative 
risk = 0.72, 95% CI = 0.55–0.95). Approximately 58% of the reduced cardiac mortality was 
attributable to reductions in primary CVD risk factors, especially reduced smoking 
prevalence. Physically active participants in this study also reported lower rates of smoking, 
and engaging in health behavior change might promote positive effects in several domains 
of lifestyle. Thus, smoking cessation might also be viewed as an intermediate mechanism in 
the association between physical activity and CVD risk because exercise has been used as an 
effective intervention in smoking cessation (20). In a prospective cohort study of 
predominantly male CHD patients, physical inactivity was associated with subsequent CVD 
events, independent of age, baseline disease severity, current smoking, and medication 
nonadherence. Other significant metabolic predictors of CVD events included diabetes and 
CRP (23). However, other factors such as blood pressure and resting heart rate did not 
contribute to the reduction in risk of CVD in this cohort. Franco et al. (5) evaluated risk of 
CVD death in males and females with preexisting CVD in the Framingham cohort. The HR 
for high compared with low physical activity level for CVD death was 0.67 (95% CI = 0.58–
0.77). After adjustment for age, sex, smoking, and other comorbidities (including diabetes 
and left ventricular hypertrophy), the HR was reduced by 7% and a further 3% after 
adjustment for body mass index and hypertension. Our findings are similar to Mora et al. 
(13), who showed that an inverse association between physical activity and CVD risk was 
mediated in substantial part by known risk factors, particularly inflammatory/hemostatic 
factors and blood pressure in 27,055 apparently healthy women. 
In total, our measured variables explained an estimated 25.6% of the MVPA–CVD 
association, which is similar to that in our previous study that contained only healthy 
participants (7). In both studies, inflammatory mechanisms seemed to be important, thus 
suggesting that some cardioprotective mechanisms of physical activity may be similar in 
both primary and secondary prevention. Short-term exercise training in CAD patients has 
been shown to reduce CRP and other proinflammatory cytokines (6). Also, an elevated CRP 
level is a significant predictor of adverse cardiovascular events independently of baseline 
characteristics and treatments in CHD patients (17,19). We did not obtain measures of 
endothelial function, which is also an important prognostic indicator in CHD patients and 
can be modified by exercise training (24). The inclusion of this measure might have 
explained additional variance. 
Resting heart rate is thought to be a crude indicator of cardiorespiratory fitness. Lower 
resting heart rate was observed in the physically active participants from the present study 
possibly reflecting better cardiac autonomic control. Resting heart rate was not, however, 
associated with cardiovascular death and did not explain the inverse association between 
MVPA and death. Previous studies have indicated strong associations between exercise 
capacity and mortality in patients referred for exercise testing (14,15). However, both an 
impaired capacity to increase heart rate during exercise testing (chronotropic incompetence) 
and a slowed rate of recovery after exercise have been associated with all-cause mortality 
(15) and may be considerably stronger predictors than resting heart rate. In addition, the 
effects of physical activity on cardiovascular health may be partly independent of 
cardiorespiratory fitness. 
Given that lower levels of physical activity could reflect greater disease severity, we cannot 
discount reverse causality. We did, however, attempt to control for this potential bias by 
removing all deaths occurring in the first 2 yr of follow-up, which did not significantly 
change the nature of our findings or alter the results. The present study was based on a 
baseline data collection and subsequent mortality follow-up with no physical activity and 
other risk factor follow-up measurement. Thus, we cannot exclude the possibility that 
changes in physical activity behavior over time could have influenced our results. Indeed, 
other data suggest that men with CHD who became inactive were at the highest risk of 
mortality at follow-up (22). Because the Health Survey for England physical activity 
interview has been shown to overestimate actual activity in less active older adults with 
heart disease (16), the present results may have underestimated the strength of associations 
between activity and mortality risk. Our findings should therefore be extended and 
replicated by using more objective physical activity measures, such as accelerometry 
recordings. Lastly, the participants excluded from our study were slightly older and thus 
probably had poorer health and greater disease burden, which could have introduced bias 
into the analyses. However, the associations between physical activity and mortality in the 
subsample used in the present analysis were largely representative of the overall cohort. 
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